Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells

29 Jun 2024

Abstract excerpt

Researchers are encountering challenges in addressing the issue of cancer cells becoming unresponsive to various chemotherapy treatments due to drug resistance. This study was designed to study the influence of antioxidant resveratrol (RSV) to sensitize resistant breast cancer (BC) cells toward tamoxifen (TAM). The cytotoxic effects of RSV and TAM against TAM-resistant LCC2 cells and their parental michigan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to MicroRNA in disease regulation
Share to RNA Interference and Gene Delivery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38943449
DOI: 10.1002/ardp.202400261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cellsPMID 38943449Read ↗

Tamoxifen resistance induction results in mitoxantrone resistance in MCF-7 breast cancer cells via upregulation of ABCG2 expressionSemantic proximity Read ↗

Meta-Analysis of the Antioxidant and Antitumor Effects of Resveratrol in Animal Models of Breast Cancer: Integrative Review for Clinical Study DesignSemantic proximity Read ↗

The role of microRNAs on doxorubicin drug resistance in breast cancerSemantic proximity Read ↗

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem CellsSemantic proximity Read ↗

The Interleukin-6/Signal Transducer and Activator of Transcription-3/Cystathionine γ-Lyase Axis Deciphers the Transformation Between the Sensitive and Resistant Phenotypes of Breast Cancer Cells.Semantic proximity Read ↗

Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic–Mediating MachinerySemantic proximity Read ↗

Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic StrategiesSemantic proximity Read ↗

Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrolSemantic proximity Read ↗

HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cellsSemantic proximity Read ↗

Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes.Semantic proximity Read ↗

Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genesSemantic proximity Read ↗

Tualang Honey Promotes Apoptotic Cell Death Induced by Tamoxifen in Breast Cancer Cell LinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.